Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-13
2010-11-02
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S374000, C514S376000, C514S392000, C514S365000, C514S228200, C514S339000, C514S254090, C514S235200, C514S323000, C514S397000, C514S383000, C514S406000, C514S407000, C514S369000, C514S367000, C514S375000, C514S364000, C514S256000, C514S378000, C514S255050, C548S468000, C548S466000, C548S235000, C548S485000, C548S486000, C548S229000, C548S312100, C548S200000, C548S205000, C548S266400, C548S364700, C548S217000, C548S224000, C548S159000, C548S131000, C548S249000, C544S062000, C544S373000, C544S144000, C544S
Reexamination Certificate
active
07825155
ABSTRACT:
Disclosed is a compound represented by the formula (1) below, a prodrug thereof or a pharmaceutically acceptable salt of either, which is useful as a therapeutic, preventive or ameliorating agent for diabetes and the like.(In the formula, R3represents an optionally substituted carbamoyl group or the like; X represents a hydroxyl group or the like; W1and W2independently represent a single bond or methylene; R7and R8independently represent a hydrogen atom, an optionally substituted alkyl group or the like; and Ar represents an optionally substituted aryl group or the like.)
REFERENCES:
patent: 6576656 (2003-06-01), Tokunaga et al.
patent: 6939887 (2005-09-01), Okazaki et al.
patent: WO-2005/035498 (2005-04-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, pp. 205-213.
Dezaki et al. Pharmacology & Therapeutics 2008, 118, pp. 239-249.
Rautio et al. Nature Reviews Drug Discovery 2008, 7, pp. 255-270.
Wang et al. Drug Delivery: Principles and Applications, 2005 John Wiley & Sons, Inc. Publication, Section 8.3, pp. 136-137.
Smith, D. A. Current Opinion in Drug Discovery & Development 2007, 10, 550-559.
Testa, B. Current Opinion in Chemical Biology 2009, 13, pp. 338-344.
Nagata Ryu
Takasaki Tsuyoshi
Tokunaga Teruhisa
Yoshida Kozo
Anderson Rebecca L
Birch & Stewart Kolasch & Birch, LLP
Coughlin Matthew P
Dainippon Sumitomo Pharma Co. ,Ltd.
LandOfFree
Oxindole derivative as feeding control agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxindole derivative as feeding control agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxindole derivative as feeding control agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4154977